Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex

Huang, Ying, Wu, Zhiping, Riwanto, Meliana, Gao, Shengqiang, Levison, Bruce S., Gu, Xiaodong, Fu, Xiaoming, Wagner, Matthew A. +16 more·2013·Journal of Clinical Investigation

DOI 10.1172/jci67478

Cited by (269)

Items 101–200 of 269

Insights into the role of paraoxonase 2 in human pathophysiology
Fauzia Parween, Tarkeshwar Gupta · 2022 · Journal of Biosciences
Development and Validation of a Predictive Model for Coronary Artery Disease Using Machine Learning
Chen Wang, Yue Zhao, Bingyu Jin, Xuedong Gan, Bin Liang, Yang Xiang, Xiaokang Zhang, Zhibing Lu, Fang Zheng · 2021 · Frontiers in Cardiovascular Medicine
Understanding Myeloperoxidase-Induced Damage to HDL Structure and Function in the Vessel Wall: Implications for HDL-Based Therapies
Gunther Marsche, Julia T. Stadler, Julia Kargl, Michael Holzer · 2022 · Antioxidants
Impaired antioxidant HDL function is associated with premature myocardial infarction
Klaus Distelmaier, Franz Wiesbauer, Hermann Blessberger, Stanislav Oravec, Lore Schrutka, Christina Binder, Elisabeth Dostal, Martin Schillinger, Johann Wojta, Irene Marthe Lang et al. · 2015 · European Journal of Clinical Investigation
Caenorhabditis elegans paraoxonase-like proteins control the functional expression of DEG/ENaC mechanosensory proteins
Yushu Chen, Shashank Bharill, Zeynep F. Altun, Robert O’Hagan, Brian Coblitz, Ehud Y. Isacoff, Martin Chalfie · 2016 · Molecular Biology of the Cell
The HDL from septic-ARDS patients with composition changes exacerbates pulmonary endothelial dysfunction and acute lung injury induced by cecal ligation and puncture (CLP) in mice
Yang Liu, Sijie Liu, Silu Han, Yuhan Hu, Zhipeng Wu, Xiaoqian Shi, Baosen Pang, Yingmin Ma, Jiawei Jin · 2020 · Respiratory Research
Apolipoprotein A-I and Cholesterol Efflux
Ali Javaheri, Daniel James Rader · 2014 · Circulation Research
Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis
Luxia Song, Jie Zhang, Runmin Lai, Qiuyi Li, Jianqing Ju, Hao Xu · 2021 · Frontiers in Pharmacology
Oxidative modification of HDL by lipid aldehydes impacts HDL function
Reza Fadaei, Sean S. Davies · 2022 · Archives of Biochemistry and Biophysics
Interactions between Paraoxonase 1 Genetic Polymorphisms and Smoking and Their Effects on Oxidative Stress and Lung Cancer Risk in a Korean Population
Sang‐Yong Eom, Dong‐Hyuk Yim, Chul‐Ho Lee, Kang‐Hyeon Choe, Jin Young An, Kye Young Lee, Yong‐Dae Kim, Heon Kim · 2015 · PLoS ONE
Myeloperoxidase-mediated oxidation targets serum apolipoprotein A-I in diabetic patients and represents a potential mechanism leading to impaired anti-apoptotic activity of high density lipoprotein
Naihao Lu, Shiliang Xie, Jiayu Li, Rong Tian, Yiyuan Peng · 2014 · Clinica Chimica Acta
iTRAQ-based proteomic analysis of plasma reveals abnormalities in lipid metabolism proteins in chronic kidney disease-related atherosclerosis
Magdalena Łuczak, Dorota Formanowicz, Łukasz Marczak, Joanna Suszyńska-Zajczyk, Elżbieta Pawliczak, Maria Wanic-Kossowska, Maciej Stobiecki · 2016 · Scientific Reports
High-Density Lipoproteins
Arash Haghikia, Ulf Landmesser · 2018 · Cardiology Clinics
Reactive Dicarbonyl Scavenging Effectively Reduces MPO-Mediated Oxidation of HDL and Restores PON1 Activity
Jiansheng Huang, Patricia G. Yancey, Huan Tao, Mark S. Borja, Loren E. Smith, Valentina Kon, Sean S. Davies, MacRae F. Linton · 2020 · Nutrients
Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: Implications for cardiac outcome
Robin P. F. Dullaart, Uwe J.F. Tietge, Arjan J. Kwakernaak, Bert D. Dikkeschei, Frank G. Perton, René A. Tio · 2014 · Atherosclerosis
Novel mechanism of regulation of the 5-lipoxygenase/leukotriene B4 pathway by high-density lipoprotein in macrophages
Shigeyasu Tsuda, Masakazu Shinohara, Toshihiko Oshita, Manabu Nagao, Nobuaki K. Tanaka, Takeshige Mori, Tetsuya Hara, Yasuhiro Irino, Ryuji Toh, Tatsuro Ishida et al. · 2017 · Scientific Reports
Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
Boda Zhou, Lingyun Zu, Yong Chen, Xi‐Long Zheng, Yuhui Wang, Bing Pan, Min Dong, Enchen Zhou, Mingming Zhao, Youyi Zhang et al. · 2017 · Lipids in Health and Disease
Circulating Lactonase Activity but Not Protein Level of PON-1 Predicts Adverse Outcomes in Subjects with Chronic Kidney Disease
Chrysan J. Mohammed, Yanmei Xie, Pamela S. Brewster, Subhanwita Ghosh, Prabhatchandra R. Dube, Tiana Sarsour, Andrew L. Kleinhenz, Erin L. Crawford, Deepak K Malhotra, Richard William James et al. · 2019 · Journal of Clinical Medicine
Mechanisms of Post-critical Illness Cardiovascular Disease
Andrew Owen, Jaimin M. Patel, Dhruv Parekh, Mansoor Nawaz Bangash · 2022 · Frontiers in Cardiovascular Medicine
Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity
Geetika Aggarwal, Linda Zhang, Valery N. Yermalitsky, Sergey Dikalov, Maxim A. Voinov, Venkataraman Amarnath, Valentina Kon, MacRae F. Linton, Kasey C. Vickers, Sean S. Davies · 2021 · Journal of Biological Chemistry
High density lipoprotein in atherosclerosis and coronary heart disease: Where do we stand today?
Evangelia Zvintzou, Dimitra Sotiria Karampela, Angeliki Vakka, Eva Xepapadaki, Eleni A. Karavia, Aikaterini Hatziri, Panagiota C. Giannopoulou, Kyriakos E. Kypreos · 2021 · Vascular Pharmacology
Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients.
Sowmya Varadhan, R Venkatachalam, S M Perumal, S S Ayyamkulamkara · 2022 · PubMed Central
Proteome Dynamics Reveals Pro-Inflammatory Remodeling of Plasma Proteome in a Mouse Model of NAFLD
Ling Li, Gürkan Bebek, Stephen F. Previs, Jonathan D. Smith, Rovshan G. Sadygov, Arthur J. McCullough, Belinda B. Willard, Takhar Kasumov · 2016 · Journal of Proteome Research
Accelerated Age-Related Arterial Stiffness in Systemic Lupus Erythematosus Patients
Fa ming Ding, Mengtao Li, Xinglin Yang, Yicong Ye, Lin Kang, Haiyu Pang, Qian Wang, Dong Xu, Xiaofeng Zeng, Shuyang Zhang · 2016 · JCR Journal of Clinical Rheumatology
Decreases in Paraoxonase-1 Activities Promote a Pro-inflammatory Effect of Lipids Peroxidation Products in Non-smoking and Smoking Patients with Acute Pancreatitis
Grzegorz Marek, Milena Ściskalska, Zygmunt Grzebieniak, Halina Milnerowicz · 2018 · International Journal of Medical Sciences
Associations between the lipid profile and the development of hypertension in young individuals – the preliminary study
Piotr Chruściel, Paulina Stemplewska, Adam Stemplewski, Mohamad Wattad, Agata Magdalena Bielecka-Dabrowa, Marek Maciejewski, Peter Edward Penson, Marcin A. Bartłomiejczyk, Maciej Banach · 2019 · Archives of Medical Science
Efficient Site-Specific Prokaryotic and Eukaryotic Incorporation of Halotyrosine Amino Acids into Proteins
Hyo Sang Jang, Xiaodong Gu, Richard B. Cooley, Joseph J. Porter, Rachel L. Henson, Taylor S. Willi, Joseph A. DiDonato, Stanley L. Hazen, Ryan A. Mehl · 2020 · ACS Chemical Biology
Distribution of Paraoxonase‐1 (PON‐1) and Lipoprotein Phospholipase A2 (Lp‐PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
Angelina Passaro, Giovanni Battista Vigna, Arianna Romani, Juana María Sanz, Carlotta Cavicchio, Gloria Bonaccorsi, Giuseppe Valacchi, Carlo Cervellati · 2018 · Oxidative Medicine and Cellular Longevity
A Potential Interplay between HDLs and Adiponectin in Promoting Endothelial Dysfunction in Obesity
Monica Zocchi, Matteo Giovanni Della Porta, Federico Lombardoni, Roberta Scrimieri, Gianvincenzo Zuccotti, Jeanette A.M. Maier, Roberta Cazzola · 2022 · Biomedicines
Antioxidant and lipid-regulating effects of probucol combined with atorvastatin in patients with acute coronary syndrome.
Yu-Song Guo, Caixia Wang, Jian Jing Cao, Jin-Liao Gao, Xiao Zou, Yi-Hong Ren, Fan Li · 2015 · PubMed Central
High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease
Magdalena Rysz-Górzyńska, Anna Gluba-Brzózka, Maciej Banach · 2016 · Current Vascular Pharmacology
Investigation of Metabolic Factors Associated with eGFR Decline Over 1 Year in a Japanese Population without CKD
K. Hayashi, M. Takayama, T. Abe, T. Kanda, H. Hirose, R. Shimizu-Hirota, E. Shiomi, Y. Iwao, H. Itoh · 2017 · Journal of atherosclerosis and thrombosis
HDL and Oxidation
Qi Zhang, Zongzhe Jiang, Yong Xu · 2022 · Advances in experimental medicine and biology
Protein markers of dysfunctional HDL in scavenger receptor class B type I deficient mice
Jia Cao, Yanyong Xu, Feifei Li, Liang Shang, Daping Fan, Hong Yu · 2018 · Journal of Translational Medicine
HDL-cholesterol, genetics, and coronary artery disease: the myth of the ‘good cholesterol’?
Ulf Landmesser, Stanley L. Hazen · 2018 · European Heart Journal
The pattern of apolipoprotein A-I lysine carbamylation reflects its lipidation state and the chemical environment within human atherosclerotic aorta
Shawna Battle, Valentin Gogonea, Belinda B. Willard, Zeneng Wang, Xiaoming Fu, Ying R. Huang, Linda M. Graham, Scott J. Cameron, Joseph A. DiDonato, John W. Crabb et al. · 2022 · Journal of Biological Chemistry
Paraoxonase 1 activity in patients with Alzheimer disease: Systematic review and meta-analysis.
M. Zuin, V. Rosta, A. Trentini, C. Bosi, G. Zuliani, C. Cervellati · 2023 · Chemico-Biological Interactions
Molecular Structure of Paraoxonase-1 and Its Modifications in Relation to Enzyme Activity and Biological Functions—A Comprehensive Review
Dominika Lewoń-Mrozek, Julia Kurzynoga, Piotr Jędrzejewski, Karolina Kędzierska, Alicja Partyka, Magdalena Kuriata-Kordek, Milena Ściskalska · 2024 · International Journal of Molecular Sciences
Network-Based Analysis on Orthogonal Separation of Human Plasma Uncovers Distinct High Density Lipoprotein Complexes
Hailong Li, Scott M. Gordon, Xiaoting Zhu, Jingyuan Deng, Debi K. Swertfeger, William Sean Davidson, Long Jason Lu · 2015 · Journal of Proteome Research
Paraoxonase 1, HDL Subclasses and Post Surgery Acute Inflammation: A Pilot Study
Yasmin Bains, Russell J. Caccavello, Kazuhiko Kotani, Alejandro Gugliucci · 2019 · Antioxidants
Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis
Maryam Zamanian-Daryoush, Valentin Gogonea, Anthony J. DiDonato, Jennifer A. Buffa, Ibrahim Choucair, Bruce S. Levison, Randall A. Hughes, Andrew D. Ellington, Ying R. Huang, Xinmin S. Li et al. · 2020 · Journal of Biological Chemistry
High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: A report from the CREDO-Kyoto registry cohort-2
Masayasu Izuhara, Koh Ono, Hiroki Shiomi, Takeshi Morimoto, Yutaka Furukawa, Yoshihisa Nakagawa, Satoshi Shizuta, Tomohisa Tada, Junichi Tazaki, Takahiro Horie et al. · 2015 · Atherosclerosis
Paraoxonase 1 in endothelial cells impairs vasodilation induced by arachidonic acid lactone metabolite
Dan Gilad, Shahar Atiya, Ziv Mozes-Autmazgin, Rotem Shelly Ben‐Shushan, Raz Ben-David, E. Amram, Snait Tamir, Dimitry Chuyun, Andrea J. Szuchman-Sapir · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Plasma Levels of Preβ1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease
Agnieszka Kuchta, Agnieszka Ćwiklińska, Monika Czaplińska, Ewa Wieczorek, Barbara Kortas‐Stempak, Anna Gliwińska, Kamil Dąbkowski, Kornelia Sałaga-Zaleska, Agnieszka Mickiewicz, Alicja Maria Dębska-Ślizień et al. · 2019 · International Journal of Molecular Sciences
Mutual Influences between Nitric Oxide and Paraoxonase 1
Marta Marín, Carlos Moya, Salvador Máñez · 2019 · Antioxidants
Deficit schizophrenia and its features are associated with PON1 Q192R genotypes and lowered paraoxonase 1 (PON1) enzymatic activity: effects on bacterial translocation
Andressa Keiko Matsumoto, Michael H. J. Maes, Thitiporn Supasitthumrong, Annabel Maes, Ana Paula Michelin, Laura de Oliveira Semeão, João Victor de Lima Pedrão, Estefânia Gastaldello Moreira, Buranee Kanchanatawan, Décio Sabbatini Barbosa · 2020 · CNS Spectrums
Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease
Jolanta Parada-Turska, Grażyna Wójcicka, Jerzy Bełtowski · 2020 · Antioxidants
Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease
Chiz-Tzung Chang, Chao‐Yuh Yang, Fuu‐Jen Tsai, Shih-Yi Lin, Chao‐Jung Chen · 2015 · BioMed Research International
Hyperlipidemia Determines Dysfunctional HDL Production and Impedes Cholesterol Efflux in the Small Intestine: Alleviation by Ginger Extract
Teodora Barbălată, Mariana Deleanu, Mihaela Georgiana Carnuta, Loredan Stefan Niculescu, Mina Răileanu, Anca Volumnia Sima, Camelia Sorina Stancu · 2019 · Molecular Nutrition & Food Research
HDL Is Not Dead Yet
Shuhui Wang Lorkowski, Jonathan D. Smith · 2022 · Biomedicines
High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms
C. Roger White, Samantha S. Giordano, G.M. Anantharamaiah · 2016 · Chemistry and Physics of Lipids
The lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, Gerwyn, Berk, Michael, Walder, Ken, O’Neil, Adrienne, Maes, Michael, Puri, Basant K. · 2021 · Neuroscience & Biobehavioral Reviews
High-density lipoprotein regulates angiogenesis by affecting autophagy via miRNA-181a-5p
Bi-Ang Kang, Hua-Ming Li, Ya-Ting Chen, Meng-Jie Deng, Yan Li, Yue-Ming Peng, Jian-Jun Gao, Zhi-Wei Mo, Jia‐Guo Zhou, Zhi‐Jun Ou et al. · 2023 · Science China Life Sciences
Excesive consumption of unsaturated fatty acids leads to oxidative and inflammatory instability in Wistar rats
Jelica D. Grujić-Milanović, Zoran Miloradović, Nevena Mihailovic‐Stanojevic, Vojislav V. Banjac, Strahinja Vidosavljević, Milan Ivanov, Danijela Karanović, Una-Jovana Vajić, Djurdjica Jovović · 2021 · Biomedicine & Pharmacotherapy
Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes
Alejandro Gugliucci, Russell J. Caccavello, H Nassar, Wiessam Abu Ahmad, Ronit Sinnreich, J. D. Kark · 2015 · Clinica Chimica Acta
Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis
Jun Watanabe, Kazuhiko Kotani, Alejandro Gugliucci · 2021 · Antioxidants
Multi-targeted therapy resistance via drug-induced secretome fucosylation
Mark Borris D. Aldonza, Junghwa Cha, Insung Yong, Jayoung Ku, Pavel G. Sinitcyn, Dabin Lee, Ryeong-Eun Cho, Roben Delos Reyes, Dongwook Kim, Soyeon Kim et al. · 2023 · eLife
Relevance of Lipoprotein Composition in Endothelial Dysfunction and the Development of Hypertension
Lisette Monsibaez Ramírez-Melo, Diego Estrada-Luna, María Esther Rubio-Ruiz, Araceli Castañeda Ovando, Eduardo Fernández‐Martínez, Angélica Saraí Jiménez‐Osorio, Oscar A Pérez-Méndez, Elizabeth Carreón‐Torres · 2025 · International Journal of Molecular Sciences
Applying Proteomics and Integrative “Omics” Strategies to Decipher the Chronic Kidney Disease-Related Atherosclerosis
Joanna Tracz, Magdalena Łuczak · 2021 · International Journal of Molecular Sciences
Protective effects of Xiongshao Capsule (芎芍胶囊) on anti-inflammatory function of high-density lipoprotein in an atherosclerosis rabbit model
Yan-hong Zhang, Ying Zhang, Jing Li, Wen-xin Tong, Fengqin Xu · 2015 · Chinese Journal of Integrative Medicine
Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications
Noémi Zsíros, Péter Koncsos, Hajnalka Lőrincz, Ildikó Seres, Mónika Katkó, Anita Szentpéteri, Viktoria Evelin Varga, Péter Fülöp, György Paragh, Mariann Harangi · 2016 · Clinical Biochemistry
Paraoxonase-1 is a better indicator than HDL of Atherosclerosis – A pilot study in North Indian population
Kamna Singh, Ritu Singh, Sudhir Chandra, Sanjay Tyagi · 2017 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
Untying the correlation between apolipoproteins and rheumatoid arthritis
Rashita Makkar, Tapan Behl, Arun Kumar, Md. Sahab Uddin, SIMONA GABRIELA BUNGAU · 2020 · Inflammation Research
Analysis of Covalent Modifications of Proteins by Oxidized Phospholipids Using a Novel Method of Peptide Enrichment
Detao Gao, Belinda B. Willard, Eugene A. Podrez · 2013 · Analytical Chemistry
Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality
Abdolkarim Mahrooz, Yasaman Shokri, Atena Variji, Mehryar Zargari, Ahad Alizadeh, Ehsan Mehtarian · 2020 · Nutrition Metabolism and Cardiovascular Diseases
Role of PON in Anoxia-Reoxygenation Injury: A Drosophila Melanogaster Transgenic Model
Juan Carlos Caraballo, Jennifer A. Borcherding, Michael R. Rector, Emma E. Hornick, David Anthony Stoltz, Joseph Zabner, Alejandro P. Comellas · 2014 · PLoS ONE
HDL subfraction distribution and HDL function in untreated dyslipidemic patients
Mariann Harangi, Anita Szentpéteri, Bíborka Nádró, Hajnalka Lőrincz, Ildikó Seres, Dénes Páll, György Paragh · 2017 · Vessel Plus
Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients
Anita Szentpéteri, Hajnalka Lőrincz, Sándor Somodi, Viktoria Evelin Varga, György Paragh, Ildikó Seres, György Paragh, Mariann Harangi · 2018 · Lipids in Health and Disease
HDL metabolism and function in diabetes mellitus
Blake J. Cochran, Thomas W King, Kévin Chemello, Shane Ross Thomas, Kerry‐Anne Rye · 2025 · Nature Reviews Endocrinology
Unresolved Systemic Inflammation, Long COVID, and the Common Pathomechanisms of Somatic and Psychiatric Comorbidity
Chih‐Sung Liang, Piotr Gałecki, Kuan‐Pin Su · 2022 · Journal of Clinical Medicine
Evaluation of in vitro effect, molecular docking, and molecular dynamics simulations of some dihydropyridine‐class calcium channel blockers on human serum paraoxonase 1 (hPON1) enzyme activity
Başak Gökçe, Muhammed Tılahun Muhammed · 2023 · Biotechnology and Applied Biochemistry
Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection fraction
Benjamin Michel Sasko, Theodoros Kelesidis, Sawa Kostin D, Linda Scharow, Rhea Mueller, Monique Jänsch, Jan Wintrich, Martin Christ, Oliver Ritter, Christian Ukena et al. · 2025 · Clinical Research in Cardiology
The pleiotropic effects of high-density lipoproteins and apolipoprotein A-I
Shane Ross Thomas, Yunjia Zhang, Kerry‐Anne Rye · 2022 · Best Practice & Research Clinical Endocrinology & Metabolism
Evaluation of the paraoxonase-1 kinetic parameters of the lactonase activity by nonlinear fit of progress curves
Marko Goličnik, Aljoša Bavec · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL
Irene Schilcher, Julia T. Stadler, Margarete Lechleitner, Andelko Hrzenjak, Andrea Berghold, Gudrun Pregartner, Marie Lhomme, Michael Holzer, Melanie Korbelius, Florian Reichmann et al. · 2021 · International Journal of Molecular Sciences
Modulation of the antioxidant enzyme paraoxonase-1 for protection against cardiovascular diseases
Waleska Cláudia Dornas, Maísa Silva · 2024 · Nutrition Metabolism and Cardiovascular Diseases
Perioperative high density lipoproteins, oxidative stress, and kidney injury after cardiac surgery
Loren E. Smith, Derek K. Smith, Patricia G. Yancey, Valentina Kon, Alan Thomas Remaley, Frederic T. Billings, MacRae F. Linton · 2021 · Journal of Lipid Research
Pro-oxidant HDL predicts poor outcome in patients with ST-elevation acute coronary syndrome
Klaus Distelmaier, Lore Schrutka, Veronika Seidl, Max P. Winter, Raphael Wurm, Andreas Mangold, Thomas Perkmann, Gerald Maurer, Christopher Adlbrecht, Irene Marthe Lang · 2015 · Thrombosis and Haemostasis
HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation
Νικόλαος Παπαγεωργίου, Effimia Maria Zacharia, Emmanuel S. Androulakis, Αlexandros Briasoulis, Marietta Charakida, Dimitris Tousoulis · 2016 · Expert Opinion on Therapeutic Targets
Relationship between rs854560PON1Gene Polymorphism and Tobacco Smoking with Coronary Artery Disease
Joanna Iwanicka, Tomasz Iwanicki, Paweł Niemiec, Tomasz Nowak, Jolanta Krauze, Władysław Grzeszczak, Sylwia Barbara Górczyńska-Kosiorz, Anna Ochalska-Tyka, Iwona Żak · 2017 · Disease Markers
Klinische Bedeutung des HDL-Cholesterins
Winfried März, Marcus Edi Kleber, Hubert Scharnagl, Thimoteus Speer, Stephen Zewinger, Andreas Ritsch, Klaus Georg Parhofer, Arnold von Eckardstein, Ulf Landmesser, Ulrich Laufs · 2016 · Herz
Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins: a randomized clinical trial
Chan Joo Lee, Seungbum Choi, Dong Huey Cheon, Kyeong Yeon Kim, Eun Jeong Cheon, Soo-jin Ann, Hye-Min Noh, Sungha Park, Seok‐Min Kang, Donghoon Choi et al. · 2017 · Lipids in Health and Disease
Investigation of Paraoxonase-1 Genotype and Enzyme-Kinetic Parameters in the Context of Cognitive Impairment in Parkinson’s Disease
Boštjan Petrič, Sara Redenšek, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec · 2023 · Antioxidants
Cardiac apoptosis caused by elevated cholesterol level in experimental autoimmune myocarditis
He Chang, Yue Wang, Yang Wu, Ping Ma, Ying Song, Chunxiao Liu, Ying Ye, Jianhua Qi, Zhi Qi · 2020 · Experimental Cell Research
Shift of the interconnection from the reaction system of paraoxonase 1 to the peroxidation reaction system of myeloperoxidase with HDL-C levels: A marker of atherosclerosis in patients with normal cholesterol levels
Fan Wang, Yawen Liu, Yetong Cong, Pengpeng Li, Yong Li, Zhihui Yan, Yuan Tang, Yi Cheng, Yang Zheng · 2014 · Clinica Chimica Acta
Relationship of high‐density lipoprotein subfractions and apolipoprotein A‐I with fat in the pancreas
Yutong Liu, Xiatiguli Shamaitijiang, Loren Skudder‐Hill, Wandia Kimita, Ivana Roosevelt Sequeira, Maxim S. Petrov · 2024 · Diabetes Obesity and Metabolism
High-density lipoproteins. Part 2. Impact of disease states on functionality
Anna Gluba-Brzózka, Robert Olszewski, Beata Franczyk, Ewelina Młynarska, Magdalena Rysz-Górzyńska, Jacek Rysz, Stanisław Surma, Sohum Sheth, Maciej Banach, Peter Paul Toth · 2025 · American Journal of Preventive Cardiology
Paraoxonase 1 gene polymorphisms concerning non-insulin-dependent diabetes mellitus nephropathy in hemodialysis patients
Alicja Ewa Grzegorzewska, Kamila Ostromecka, Paulina Adamska, Adrianna Mostowska, Wojciech J. Warchol, Paweł Piotr Jagodziński · 2020 · Journal of Diabetes and its Complications
High-density lipoprotein-based drug discovery for treatment of atherosclerosis
Yu Du, Li Wang, B. Hong · 2015 · Expert Opinion on Drug Discovery
Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome
Scott M. Gordon, Hailong Li, Xiaoting Zhu, Patrick Tso, Catherine A. Reardon, AMY SANGHAVI SHAH, Long Jason Lu, William Sean Davidson · 2016 · Journal of Proteomics
Association of Paraoxonase1 enzyme and its genetic single nucleotide polymorphisms with cardio-metabolic and neurodegenerative diseases
Humira Jeelani, Nahida Tabassum, Dil Afroze, Fouzia Rashid · 2020 · Gene Reports
24. Cholesterol and vitamin D: how the ‘mother’ and ‘daughter’ molecules interact
B. Nkooyeh, Tirang Reza Neyestani · 2016 · Wageningen Academic Publishers eBooks
Fibroblast growth factor-21, epidermal growth factor receptor, interleukine-6, myeloperoxidase, lipid hydroperoxide, apoAI, apoB concentration, and lipid and lipoprotein ratios, as diagnostic serum biomarkers for gastric cancer
Elżbieta Kimak, Kamil Nurczyk, Tomasz Skoczylas, Dariusz Duma, Renata Gieroba, Janusz Solski · 2019 · Polskie Archiwum Medycyny Wewnętrznej
Myeloperoxidase-Mediated Dysfunctional High-Density Lipoprotein
Godfrey S. Getz, Catherine A. Reardon · 2014 · Arteriosclerosis Thrombosis and Vascular Biology
Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease
Arash Haghikia, Ulf Landmesser · 2018 · JACC Basic to Translational Science
A Novel Indicator for HDL Functionality
Yasuhiro Irino, Ryuji Toh, Tatsuro Ishida · 2019 · Journal of Atherosclerosis and Thrombosis
Підбір умов для спектрофотометричного визначення активності параоксонази з 4-нітрофенілацетатом у плазмі та печінці мишей
Myroslava Vatashchuk, Viktoria Hurza, Maria M. Bayliak · 2023 · Journal of Vasyl Stefanyk Precarpathian National University
Effects of Seven Weeks of Combined Physical Training on High-Density Lipoprotein Functionality in Overweight/Obese Subjects
Tiziana Bacchetti, Camilla Morresi, Gianna Ferretti, Anders Olof Larsson, Torbjörn Åkerfeldt, Michael Svensson · 2023 · Metabolites
Multiple facets of HDLs as modifiable risk factors in stroke—the good, the bad, and the ugly
Soumya Krishnamoorthy, Shankarappa Manjunatha, Deepa Damayanthi, Padmavathy Narayanan Sylaja, Srinivas Gopala · 2025 · Journal of Lipid Research
Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction
Kentaro Oniki, Masatsune Ogura, Erika Matsumoto, Hiroshi Watanabe, Tadashi Imafuku, Yuri Seguchi, Yuichiro Arima, Koichiro Fujisue, Kenshi Yamanaga, Eiichiro Yamamoto et al. · 2024 · Journal of Atherosclerosis and Thrombosis